Report from the HarmoSter study different LC-MS/MS androstenedione, DHEAS and testosterone methods compare well; however, unifying calibration is a double-edged sword

Open Access
Authors
  • F. Fanelli
  • M. Peitzsch
  • S. Bruce
  • M. Cantù
  • A. Temchenko
  • M. Mezzullo
  • J.M. Lindner
  • J.M. Hawley
  • Mariette T. Ackermans
  • J. Van den Ouweland
  • D. Koeppl
  • E. Nardi
  • F. MacKenzie
  • P.-A. Binz
  • M. Rauh
  • B.G. Keevil
  • M. Vogeser
  • G. Eisenhofer
  • A.C. Heijboer
  • U. Pagotto
Publication date 2024
Journal Clinical chemistry and laboratory medicine
Volume | Issue number 62 | 6
Pages (from-to) 1080-1091
Organisations
  • Faculty of Science (FNWI) - Van 't Hoff Institute for Molecular Sciences (HIMS)
Abstract
Objectives: Current liquid chromatography-tandem mass spectrometry (LC-MS/MS) applications for circulating androgen measurements are technically diverse. Previously, variable results have been reported for testosterone. Data are scarce for androstenedione and absent for dehydroepiandrosterone sulfate (DHEAS). We assessed the agreement of androstenedione, DHEAS and testosterone LC-MS/MS measurements among nine European centers and explored benefits of calibration system unification. Methods: Androgens were measured twice by laboratory-specific procedures in 78 patient samples and in EQA materials. Results were obtained by in-house and external calibration. Intra- and inter-laboratory performances were valued.
Results: Intra-laboratory CVs ranged between 4.2–13.2 % for androstenedione, 1.6–10.8 % for DHEAS, and 4.3–8.7 % and 2.6–7.1 % for female and male testosterone, respectively. Bias and trueness in EQA materials were within ±20 %. Median inter-laboratory CV with in-house vs. external calibration were 12.0 vs. 9.6 % for androstenedione (p<0.001), 7.2 vs. 4.9 % for DHEAS (p<0.001), 6.4 vs. 7.6 % for female testosterone (p<0.001) and 6.8 and 7.4 % for male testosterone (p=0.111). Median bias vs. all laboratory median with in-house and external calibration were −13.3 to 20.5 % and −4.9 to 18.7 % for androstenedione, −10.9 to 4.8 % and −3.4 to 3.5 % for DHEAS, −2.7 to 6.5 % and −11.3 to 6.6 % for testosterone in females, and −7.0 to 8.5 % and −7.5 to 11.8 % for testosterone in males, respectively. Conclusions: Methods showed high intra-laboratory precision but variable bias and trueness. Inter-laboratory agreement was remarkably good. Calibration system unification improved agreement in androstenedione and DHEAS, but not in testosterone measurements. Multiple components, such as commutability of calibrators and EQA materials and internal standard choices, likely contribute to inter-laboratory variability.
Document type Article
Note Publisher Copyright: © 2024 the author(s), published by De Gruyter.
Language English
Published at https://doi.org/10.1515/cclm-2023-1138
Other links https://www.scopus.com/pages/publications/85182563203
Downloads
Report from the HarmoSter study (Final published version)
Supplementary materials
Permalink to this page
Back